Fischer Imaging, Trex Medical Settle Patent Dispute
DENVER, Colo., June 11 -- Fischer Imaging and Thermo Electron Corp. have settled patent-infringement litigation that Fischer filed against Trex Medical and Hologic Inc. involving patents relating to Fischer Imaging's Mammotest stereotactic breast-biopsy system.
Trex Medical is a discontinued operation of Thermo Electron. In September 2000, Thermo Electron sold assets of Trex Medical to Hologic Inc. while retaining certain responsibilities for the ongoing patent litigation with Fischer.
Under the settlement, Fischer received $25 million in cash from Trex Medical and will also receive $7.2 million relating to a paid-up license through the remaining term of the patents for the continued sale of the breast-biopsy system now being sold by Hologic. This license will be paid in equal annual installments over the next eight years. Fischer will recognize the settlement over the original patent life of 17 years, resulting in a one-time gain of about $19.2 million and future annual license fees of about $1.9 million attributable to the remaining life of the underlying patents.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024